arrow
Back
F

Fabiana Napolitano

University of Naples Federico II

16H-index
68Paper Count
995Citation Count
Published Papers 42
Publication Date
CD8+Tcells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer
err2026-02-02
err0
errOAAI
errNapolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya R.; Gonzalez-Ericsson, Paula I.; Formisano, Luigi; Unni, Nisha; Shakeel, Shahbano; Zhu, James Z.; Ahuja, Khushi; Guo, Lei; Chica-Parrado, Maria Rosario; Matsunaga, Yuki; Luna, Pamela; Lin, Chang-Ching A.; Uemoto, Yasuaki; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel J.; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer D.; Bianco, Roberto; V. Fang, Yisheng; Xu, Lin; Lee, Jeon; Wang, Tao; Balko, Justin M.; Mills, Gordon B.; Labrie, Marilyne; Hanker, Ariella B.; Arteaga, Carlos L.
errShare
errSave
Performance of Control Arms in Trials Leading to FDA Cancer Approvals
err2026-01-01
err0
PREAI
errViggiano, Angela; Salomone, Fabio; Napolitano, Fabiana; Liguori, Luigi; Avanzo, Annarita; D'ambrosio, Simeone; Vitale, Filippo; Isernia, Maria Carmela; Russo, Anna; Longo, Lucia; Pepe, Felice; Santaniello, Antonio; Viscardi, Giuseppe; Vitiello, Fabiana; Gilli, Marina; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto
errShare
errSave
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis
err2025-12-16
err0
errOAAI
errFabio Salomone; Massimo Di Maio; Angela Viggiano; Luigi Liguori; Carminia Maria Della Corte; Giuseppe Viscardi; Fabiana Vitiello; Fabiana Napolitano; Antonio Santaniello; Antonio Nuccio; Simeone D’Ambrosio; Filippo Vitale; Annarita Avanzo; Alessandra Bulotta; Luigi Formisano; Roberto Ferrara; Roberto Bianco; Valter Torri; Alberto Servetto
errShare
errSave
Quality of Life results and survival outcomes in trials of immunotherapy in advanced cancers: a systematic review and meta-research study
err2025-09-18
err0
errOAAI
errAnnarita Avanzo; Fabio Salomone; Massimo Di Maio; Simeone D’Ambrosio; Filippo Vitale; Angela Viggiano; Luigi Liguori; Maria Carmela Isernia; Anna Russo; Lucia Longo; Fabiana Napolitano; Antonio Santaniello; Luigi Formisano; Roberto Bianco; Alberto Servetto
errShare
errSave
Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study
err2025-09-01
err1
errOAAI
errVitale, Filippo; Salomone, Fabio; Di Maio, Massimo; D'Ambrosio, Simeone; Avanzo, Annarita; Napolitano, Fabiana; Viggiano, Angela; Liguori, Luigi; Russo, Anna; Isernia, Maria Carmela; Longo, Lucia; Santaniello, Antonio; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto
errShare
errSave
Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12]
err2025-07-05
err0
PREAI
errChica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L.
errShare
errSave
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer
err2025-06-27
err0
PREAI
errMaxwell R. Lloyd; Rosario Chica-Parrado; Caroline M. Weipert; Todd C. Knepper; Emily L. Podany; Fabiana Napolitano; Dan Ye; Chang-Ching Lin; Yasuaki Uemoto; Jiemin Liao; Claire Wegrzyn; Christine M. Walko; Lianne Y. Ryan; Jennifer C. Keenan; Arielle J. Medford; Shiyuan A. Liu; Gerburg M. Wulf; Katherine K. Clifton; Cynthia X. Ma; Hyo S. Han; Nicole Zhang; Leif W. Ellisen; Aditya Bardia; Carlos L. Arteaga; Ariella B. Hanker; Seth A. Wander
errShare
errSave
Nutritional bioactive compounds with beneficial effects for multiple sclerosis: Potential implication of G-Quadruplexes?
err2025-06-06
err0
errOAAI
errAnna Maria Malfitano; Giuliano Castellano; Alessandra Croce; Fabiana Napolitano; Giuseppe Portella; Francesco Beguinot; Pietro Formisano; Francesca Fiory
errShare
errSave
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations (vol 619, 217668, 2025)
err2025-06-02
err0
errOAAI
errUemoto, Yasuaki; Lin, Chang-Ching A.; Wang, Bingnan; Ye, Dan; Fang, Yisheng, V; Bikorimana, Emmanuel; Napolitano, Fabiana; Chica-Parrado, Maria Rosario; Li, Cheung; Mendiratta, Saurabh; Chen, Chuo; Hanker, Ariella B.; Arteaga, Carlos L.
errShare
errSave
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis
err2024-12-01
err0
errOAAI
errD'Ambrosio, Simeone; Salomone, Fabio; Vitale, Filippo; Avanzo, Annarita; Viggiano, Angela; Liguori, Luigi; Ferrara, Roberto; Nuccio, Antonio; Viscardi, Giuseppe; Napolitano, Fabiana; Santaniello, Antonio; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto
errShare
errSave
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer
err2024-11-01
err0
errOAAI
errChica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L.
errShare
errSave
Mapping cellular interactions from spatially resolved transcriptomics data
err2024-09-03
err2
PREAI
errZhu, James; Wang, Yunguan; Chang, Woo Yong; Malewska, Alicia; Napolitano, Fabiana; Gahan, Jeffrey C.; Unni, Nisha; Zhao, Min; Yuan, Rongqing; Wu, Fangjiang; Yue, Lauren; Guo, Lei; Zhao, Zhuo; Chen, Danny Z.; Hannan, Raquibul; Zhang, Siyuan; Xiao, Guanghua; Mu, Ping; Hanker, Ariella B.; Strand, Douglas; Arteaga, Carlos L.; Desai, Neil; Wang, Xinlei; Xie, Yang; Wang, Tao
errShare
errSave
Assessing differential informative censoring in control and experimental arm in trials testing immunotherapy in metastatic cancers: A systematic review
err2024-09-01
err0
PREAI
errVitale, F.; Salomone, F.; D'Ambrosio, S.; Avanzo, A.; Viggiano, A.; Liguori, L.; Napolitano, F.; Santaniello, A.; Formisano, L.; Bianco, R.; Servetto, A.
errShare
errSave
Analysis of correlation between quality of life (QoL) results and survival outcomes in phase III clinical trials testing immunotherapy in metastatic cancers
err2024-09-01
err0
PREAI
errAvanzo, A.; Salomone, F.; D'Ambrosio, S.; Vitale, F.; Viggiano, A.; Liguori, L.; Napolitano, F.; Santaniello, A.; Formisano, L.; Bianco, R.; Servetto, A.
errShare
errSave
Blinded independent central review versus local investigator assessment of progression-free survival in randomized controlled trials of immunotherapy in advanced cancers: A systematic review and meta-analysis
err2024-09-01
err0
PREAI
errD'Ambrosio, S.; Salomone, F.; Vitale, F.; Avanzo, A.; Viggiano, A.; Liguori, L.; Napolitano, F.; Santaniello, A.; Formisano, L.; Bianco, R.; Servetto, A.
errShare
errSave
EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER plus breast cancer
err2024-07-01
err3
errOAAI
errBelli, Stefania; Esposito, Daniela; Ascione, Claudia M.; Messina, Francesca; Napolitano, Fabiana; Servetto, Alberto; De Angelis, Carmine; Bianco, Roberto; Formisano, Luigi
errShare
errSave
A bedside-to-bench translational analysis demonstrates that NF1 alterations promote CDK4/6 inhibitor (CDK4/6i) resistance in hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
err2024-05-02
err0
PREAI
errLloyd, Maxwell; Chica-Parrado, M. Rosario; Knepper, Todd; Lin, Chang-Ching; Podany, Emily; Walko, Christine; Napolitano, Fabiana; Weipert, Caroline; Liao, Jiemin; Medford, Arielle; Ryan, Lianne; Keenan, Jennifer; Zhang, Nicole; Liu, Shiyuan; Wulf, Gerburg; Clifton, Katherine; Ma, Cynthia; Han, Hyo; Ellisen, Leif; Bardia, Aditya; Arteaga, Carlos; Hanker, Ariella; Wander, Seth
errShare
errSave
Tumor immune microenvironment modulates resistance to estrogen suppression in ER plus breast cancer
err2024-05-02
err0
PREAI
errNapolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya; Gonzalez-Ericsson, Paula; Formisano, Luigi; Guo, Lei; Chica-Parrado, M. Rosario; Lin, Chang-Ching; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer; Fang, Yisheng; Xu, Lin; Balko, Justin; Mills, Gordon; Labrie, Marilyne; Hanker, Ariella; Arteaga, Carlos
errShare
errSave
ESR1 mutations drive resistance to CDK4/6 inhibitors in ER plus Breast Cancer
err2024-05-02
err0
PREAI
errChica-Parrado, M. Rosario; Lin, Chang-Ching; Jaeger, Ellen; Harris, Michelle; Guo, Lei; Bikorimana, Emmanuel; Napolitano, Fabiana; Chao, Calvin; Hanker, Ariella; Arteaga, Carlos
errShare
errSave
Combined inhibition of CDK4/6 and AKT is highly active against the luminal androgen receptor (LAR) subtype of triple negative breast cancer (TNBC)
err2024-03-22
err0
PREAI
errChica-Parrado, Rosario; Kim, Gun Min; Uemoto, Yasuaki; Ye, Dan; Napolitano, Fabiana; Lin, Chang-Ching; Bikorimana, Emmanuel; Lee, Kyung-Min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L.
errShare
errSave